Literature DB >> 11007914

Interrupting the inhibiton of normal hematopoiesis in myelogenous leukemia: a hypothetical approach to therapy.

M A Lichtman1.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11007914     DOI： 10.1634/stemcells.18-5-304

Source DB:  PubMed          Journal:  Stem Cells        ISSN： 1066-5099            Impact factor:   6.277


× No keyword cloud information.
  4 in total

1.  Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia.

Authors:  Benjamin J Frisch; John M Ashton; Lianping Xing; Michael W Becker; Craig T Jordan; Laura M Calvi
Journal:  Blood       Date:  2011-09-28       Impact factor: 22.113

2.  Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts.

Authors:  Maria Krevvata; Barbara C Silva; John S Manavalan; Marta Galan-Diez; Aruna Kode; Brya Grace Matthews; David Park; Chiyuan A Zhang; Naomi Galili; Thomas L Nickolas; David W Dempster; William Dougall; Julie Teruya-Feldstein; Aris N Economides; Ivo Kalajzic; Azra Raza; Ellin Berman; Siddhartha Mukherjee; Govind Bhagat; Stavroula Kousteni
Journal:  Blood       Date:  2014-08-18       Impact factor: 22.113

3.  Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia.

Authors:  S Geyh; M Rodríguez-Paredes; P Jäger; C Khandanpour; R-P Cadeddu; J Gutekunst; C M Wilk; R Fenk; C Zilkens; D Hermsen; U Germing; G Kobbe; F Lyko; R Haas; T Schroeder
Journal:  Leukemia       Date:  2015-11-25       Impact factor: 11.528

4.  Bone marrow endothelial cell-derived interleukin-4 contributes to thrombocytopenia in acute myeloid leukemia.

Authors:  Ai Gao; Yuemin Gong; Caiying Zhu; Wanzhu Yang; Qing Li; Mei Zhao; Shihui Ma; Jianyong Li; Sha Hao; Hui Cheng; Tao Cheng
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.